1. Ten-year supra-network experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis. (October 2019) Authors: Njoku, Kelechi; Ager, Michael; Serra, Maria; Beesley, Sharon; Robinson, Angus; Pickering, Lisa; Crellin, Perric; Afshar, Mehran; Vyas, Lona; Eardley, Ian; Kayes, Oliver; Elmamoun, Mamoun; Ayres, Benjamin; Henry, Ann; Watkin, Nick; Tree, Alison Journal: Clinical oncology Issue: Volume 31(2019)Supplement 1 Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long‐term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis. (27th December 2020) Authors: Ager, Michael; Njoku, Kelechi; Serra, Maria; Robinson, Angus; Pickering, Lisa; Afshar, Mehran; Vyas, Lona; Eardley, Ian; Kayes, Oliver; Elmamoun, Mamoun; Khoo, Vincent; Ayres, Benjamin; Henry, Ann; Watkin, Nick; Tree, Alison C. Journal: BJU international Issue: Volume 128:Number 4(2021) Page Start: 451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A European, prospective, observational study of enzalutamide in patients with metastatic castration‐resistant prostate cancer: PREMISE. Issue 5 (8th November 2021) Authors: Payne, Heather; Robinson, Angus; Rappe, Bernard; Hilman, Serena; De Giorgi, Ugo; Joniau, Steven; Bordonaro, Roberto; Mallick, Stéphane; Dourthe, Louis‐Marie; Flores, Moisés Mira; Gumà, Josep; Baron, Benoit; Duran, Aurea; Pranzo, Alessandra; Serikoff, Alexis; Mott, David; Herdman, Mike; Pavesi, Ma... Journal: International journal of cancer Issue: Volume 150:Issue 5(2022) Page Start: 837 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial. Issue 4 (April 2022) Authors: Dearnaley, David; Hinder, Victoria; Hijab, Adham; Horan, Gail; Srihari, Narayanan; Rich, Philip; Houston, J Graeme; Henry, Ann M; Gibbs, Stephanie; Venkitaraman, Ram; Cruickshank, Clare; Hassan, Shama; Miners, Alec; Mason, Malcolm; Pedley, Ian; Payne, Heather; Brock, Susannah; Wade, Robert; Robin... Journal: Lancet oncology Issue: Volume 23:Issue 4(2022) Page Start: 501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. Issue 10323 (29th January 2022) Authors: Attard, Gerhardt; Murphy, Laura; Clarke, Noel W; Cross, William; Jones, Robert J; Parker, Christopher C; Gillessen, Silke; Cook, Adrian; Brawley, Chris; Amos, Claire L; Atako, Nafisah; Pugh, Cheryl; Buckner, Michelle; Chowdhury, Simon; Malik, Zafar; Russell, J Martin; Gilson, Clare; Rush, Hannah;... Journal: Lancet Issue: Volume 399:Issue 10323(2022) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID). Issue 3 (20th January 2021) Authors: Crabb, Simon J.; Griffiths, Gareth; Marwood, Ellice; Dunkley, Denise; Downs, Nichola; Martin, Karen; Light, Michelle; Northey, Josh; Wilding, Sam; Whitehead, Amy; Shaw, Emily; Birtle, Alison J.; Bahl, Amit; Elliott, Tony; Westbury, Charlotte; Sundar, Santhanam; Robinson, Angus; Jagdev, Satinder; ... Journal: Journal of clinical oncology Issue: Volume 39:Issue 3(2021) Page Start: 190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial. Issue 1 (January 2020) Authors: Mateo, Joaquin; Porta, Nuria; Bianchini, Diletta; McGovern, Ursula; Elliott, Tony; Jones, Robert; Syndikus, Isabel; Ralph, Christy; Jain, Suneil; Varughese, Mohini; Parikh, Omi; Crabb, Simon; Robinson, Angus; McLaren, Duncan; Birtle, Alison; Tanguay, Jacob; Miranda, Susana; Figueiredo, Ines; Seed... Journal: Lancet oncology Issue: Volume 21:Issue 1(2020) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. Issue 10274 (13th February 2021) Authors: Langley, Ruth E; Gilbert, Duncan C; Duong, Trinh; Clarke, Noel W; Nankivell, Matthew; Rosen, Stuart D; Mangar, Stephen; Macnair, Archie; Sundaram, Subramanian Kanaga; Laniado, Marc E; Dixit, Sanjay; Madaan, Sanjeev; Manetta, Caroline; Pope, Alvan; Scrase, Christopher D; Mckay, Stephen; Muazzam, I... Journal: Lancet Issue: Volume 397:Issue 10274(2021) Page Start: 581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Radiotherapy for Prostate Cancer: is it 'what you do' or 'the way that you do it'? A UK Perspective on Technique and Quality Assurance. Issue 9 (September 2016) Authors: Bonnington, Sue; Bradshaw, Lynne; Cooper, Debbie; Elliott, Emma; Herbert, Pippa; Holding, Peter; Howson, Joanne; Jones, Mandy; Lennon, Teresa; Lyons, Norma; Moody, Hilary; Plumb, Claire; O'Sullivan, Tricia; Salter, Liz; Tidball, Sarah; Thompson, Pauline; Adam, Tonia; Askew, Sarah; Atkinson, Sharo... Journal: Clinical oncology Issue: Volume 28:Issue 9(2016) Page Start: e92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial. Issue 4 (April 2023) Authors: Sweeney, Christopher J; Martin, Andrew J; Stockler, Martin R; Begbie, Stephen; Cheung, Leanna; Chi, Kim N; Chowdhury, Simon; Frydenberg, Mark; Horvath, Lisa G; Joshua, Anthony M; Lawrence, Nicola J; Marx, Gavin; McCaffrey, John; McDermott, Ray; McJannett, Margaret; North, Scott A; Parnis, Francis... Journal: Lancet oncology Issue: Volume 24:Issue 4(2023) Page Start: 323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗